Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Immunotherapy for head and neck cancer: What, when and how long?

Perioperative immunotherapy for head and neck squamous cell carcinoma (HNSCC)

Date

22 Oct 2023

Session

Immunotherapy for head and neck cancer: What, when and how long?

Topics

Immunotherapy

Tumour Site

Head and Neck Cancers

Presenters

Athanassios Argiris

Authors

A. Argiris

Author affiliations

  • Medical Oncology Department, Hygeia Hospital, 151023 - Marousi/GR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: Immunotherapy for head and neck cancer: What, when and how long?

Resources:

Slides

Webcast

Conclusions and perspectives 

Presenter: Melvin Lee Kiang Chua

Session: Immunotherapy for head and neck cancer: What, when and how long?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.